Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verena Dederer

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|August 2, 2021
Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving NeurodegenerationDavid H Drewry, Joel K Annor-Gyamfi, Carrow I Wells, et al.
Small Methods|May 7, 2025
Native Taylor/Non-Taylor Dispersion-Mass Spectrometry (TNT-MS) Allows Rapid Protein Desalting and Multiplexed, Label-Free Ligand ScreeningJonathan Eisert, Edvaldo Vasconcelos Soares Maciel, Verena Dederer, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Science Advances|June 4, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Nature Methods|July 11, 2018
Genome-wide C-SWAT library for high-throughput yeast genome taggingMatthias Meurer, Yuanqiang Duan, Ehud Sass, et al.
Science Advances|June 7, 2024
Mechanism of human PINK1 activation at the TOM complex in a reconstituted systemOlawale G Raimi, Hina Ojha, Kenneth Ehses, et al.
The Journal of Biological Chemistry|June 14, 2024
A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2Verena Dederer, Marta Sanz Murillo, Eva P Karasmanis, et al.
EMBO Reports|February 9, 2019
The intramembrane protease SPPL2c promotes male germ cell development by cleaving phospholambanJohannes Niemeyer, Torben Mentrup, Ronny Heidasch, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
The structural basis for LRRK2's activation and autoinhibitionAmalia Villagran Suarez, Kathryn S Hatch, Tatyana Bodrug, et al.
Journal of Medicinal Chemistry|July 2, 2025
Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective InhibitorSebastian Mandel, Thomas Hanke, Niall Prendiville, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|August 2, 2021
Identification of Pyrimidine-Based Lead Compounds for Understudied Kinases Implicated in Driving NeurodegenerationDavid H Drewry, Joel K Annor-Gyamfi, Carrow I Wells, et al.
Small Methods|May 7, 2025
Native Taylor/Non-Taylor Dispersion-Mass Spectrometry (TNT-MS) Allows Rapid Protein Desalting and Multiplexed, Label-Free Ligand ScreeningJonathan Eisert, Edvaldo Vasconcelos Soares Maciel, Verena Dederer, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Type-II kinase inhibitors that target Parkinson's Disease-associated LRRK2Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Science Advances|June 4, 2025
Type II kinase inhibitors that target Parkinson's disease-associated LRRK2Nicolai D Raig, Katherine J Surridge, Marta Sanz-Murillo, et al.
Nature Methods|July 11, 2018
Genome-wide C-SWAT library for high-throughput yeast genome taggingMatthias Meurer, Yuanqiang Duan, Ehud Sass, et al.
Science Advances|June 7, 2024
Mechanism of human PINK1 activation at the TOM complex in a reconstituted systemOlawale G Raimi, Hina Ojha, Kenneth Ehses, et al.
The Journal of Biological Chemistry|June 14, 2024
A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2Verena Dederer, Marta Sanz Murillo, Eva P Karasmanis, et al.
EMBO Reports|February 9, 2019
The intramembrane protease SPPL2c promotes male germ cell development by cleaving phospholambanJohannes Niemeyer, Torben Mentrup, Ronny Heidasch, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
The structural basis for LRRK2's activation and autoinhibitionAmalia Villagran Suarez, Kathryn S Hatch, Tatyana Bodrug, et al.
Journal of Medicinal Chemistry|July 2, 2025
Covalent Targeting Leads to the Development of a LIMK1 Isoform-Selective InhibitorSebastian Mandel, Thomas Hanke, Niall Prendiville, et al.
Pageof 3